Presence of high-level VCAM-1 tied to severity of diabetic retinopathy: Study
China: A recent study published in the Journal of Diabetes and its Complications has shown the presence of a high level of vascular cell adhesion molecule-1 (VCAM-1) in patients with diabetic retinopathy (DR) related to the severity of DR.
Based on the above findings, Yinglei Xu, the Affiliated Hospital of Qingdao University, Shandong, China, and colleagues concluded that VCAM-1 is a potential detection biomarker for diabetic retinopathy.
Diabetic retinopathy, one of the common microvascular complications of diabetes, is the most common cause of blindness and visual impairment worldwide. The global prevalence of diabetic retinopathy is reported to be 27%. Diabetic retinopathy is an inflammatory disease comprising adhesion molecules. VCAM-1 is an adhesion molecule involved in tumour growth, angiogenesis, and metastasis processes. However, there needs to be more clarity on the exact role of VCAM-1 in DR, and there is a shortage of meta-analyses.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.